Recent News from (OTC: APLD)
|Advanced Plasma Products, Inc. Announces Further Development of Its Atmospheric Plasma Wound Treatment Device|
|LENOIR CITY, Tenn. , Aug. 29, 2016 /PRNewswire/ -- Advanced Plasma Products, Inc. (APP) announced today that it is nearing completion of the SBIR Phase II grant provided by the National Institute of General Medical Sciences of the National Institutes of Health. The multi-year grant a...|
|Source: PR Newswire|
|Date: August, 29 2016 16:15|
Last 5 Days Trading Activity
|Date||Open Price||Close Price||High||Low||Volume|
Last 5 Days Short Activity
|Date||Short Volume||Total Volume||Short Percentage||Short Indicator|
* Short Mode
About Applied Science Products, Inc. (OTC: APLD)
Applied Science Products Inc. operates as a technology company. The Company develops patented technology such as tailored plasma gas chemistry for a wide range of applications such as air purification, disinfection, materials processing, decontamination, and sterilization.
- Lance Cummins / Acting President
Current Share Structure
- Market Cap: $37,720 - 03/16/2018
- Authorized: 150,000,000 - 12/15/2010
- Issue and Outstanding: 8,981,000 - 12/15/2010
Daily Technical Chart for (OTC: APLD)
Stay tuned for daily updates and more on (OTC: APLD)
More to come on (OTC: APLD)
Do your DD and if you choose, be ready to go!
The Research: All source information contained in this email is from the public sources mentioned below.
Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in APLD is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of APLD and does not buy, sell, or trade any shares of APLD. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/